Providing Better Pharmaceutical Care in Internal Medicine and Hematology (IV)-Preparation of a Brochure for Patients Undergoing High Dose Ara-C Chemotherapy and its Evaluation-
WEICK, J. K. A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia : a Southwest Oncology Group study. Blood. 1996, 88, 2841-2851
BYRD, J. C. Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13 q22) or t(16;16)(p13;q22) : results from CALGB 8461. J. Clin. Oncol. 2004, 22, 1087-1094